Showing results (1-10 of 1,289) with videos related to

Sort By:
Pageof 129
Lancet (London, England)|June 1, 2005
Heart failureJohn J V McMurray, Marc A Pfeffer
The Lancet. Diabetes & Endocrinology|April 16, 2014
Heart failure: a cardiovascular outcome in diabetes that can no longer be ignoredJohn J V McMurray, Hertzel C Gerstein, Rury R Holman, et al.
Reviews in Cardiovascular Medicine|December 13, 2005
Uncertainty in the treatment of anemia in chronic kidney diseaseMarc A Pfeffer, Scott D Solomon, Ajay K Singh, et al.
Circulation|March 29, 2018
Comparison of Time-to-First Event and Recurrent-Event Methods in Randomized Clinical TrialsBrian Claggett, Stuart Pocock, L J Wei, et al.
European Heart Journal|September 21, 2006
Predictors of stroke in high-risk patients after acute myocardial infarction: insights from the VALIANT TrialUchechukwu K Sampson, Marc A Pfeffer, John J V McMurray, et al.
European Journal of Heart Failure|January 10, 2018
Association between mean systolic and diastolic blood pressure throughout the follow-up and cardiovascular events in acute myocardial infarction patients with systolic dysfunction and/or heart failure: an analysis from the High-Risk Myocardial Infarction Database InitiativeJoão Pedro Ferreira, Kevin Duarte, Marc A Pfeffer, et al.
Archives of Internal Medicine|August 13, 2008
The hemoglobin A1c level as a progressive risk factor for cardiovascular death, hospitalization for heart failure, or death in patients with chronic heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and Morbidity (CHARM) programHertzel C Gerstein, Karl Swedberg, Jonas Carlsson, et al.
JACC. Heart Failure|November 3, 2022
Steroidal MRA Across the Spectrum of Renal Function: A Pooled Analysis of RCTsJoão Pedro Ferreira, Bertram Pitt, John J V McMurray, et al.
Lancet (London, England)|September 19, 2003
Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trialJohn J V McMurray, Jan Ostergren, Karl Swedberg, et al.
Nature Reviews. Cardiology|January 26, 2012
Heart failure in 2011: Heart failure therapy--technology to the foreJohn J V McMurray
Pageof 129